Anca Bulgaru, MD

Goel S, Desai K, Karri S, Gollamudi R, Chaudhary I, Bulgaru A, Kaubisch A, Goldberg G, Einstein M, Camacho F, Baker S, Mani S. Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers. Investigational New Drugs 2007, 25: 237-45. PMID: 17195945, DOI: 10.1007/s10637-006-9028-1.

Goel S, Desai K, Bulgaru A, Fields A, Goldberg G, Agrawal S, Martin R, Grindel M, Mani S. A safety study of a mixed-backbone oligonucleotide (GEM231) targeting the type I regulatory subunit alpha of protein kinase A using a continuous infusion schedule in patients with refractory solid tumors. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2003, 9: 4069-76. PMID: 14519628.

Liu W, Bulgaru A, Haigentz M, Stein CA, Perez-Soler R, Mani S. The BCL2-family of protein ligands as cancer drugs: the next generation of therapeutics. Current Medicinal Chemistry. Anti-cancer Agents 2003, 3: 217-23. PMID: 12769779, DOI: 10.2174/1568011033482459.